Qube Research & Technologies Ltd trimmed its stake in UnitedHealth Group Inc (NYSE:UNH) by 24.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 31,140 shares of the healthcare conglomerate’s stock after selling 10,324 shares during the period. UnitedHealth Group makes up approximately 1.8% of Qube Research & Technologies Ltd’s portfolio, making the stock its 7th biggest holding. Qube Research & Technologies Ltd’s holdings in UnitedHealth Group were worth $7,598,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of the stock. Everence Capital Management Inc. raised its holdings in UnitedHealth Group by 5.1% in the second quarter. Everence Capital Management Inc. now owns 18,890 shares of the healthcare conglomerate’s stock worth $4,609,000 after purchasing an additional 910 shares in the last quarter. Capital City Trust Co. FL purchased a new stake in shares of UnitedHealth Group during the second quarter valued at $868,000. GHP Investment Advisors Inc. boosted its position in shares of UnitedHealth Group by 6.3% during the second quarter. GHP Investment Advisors Inc. now owns 14,533 shares of the healthcare conglomerate’s stock valued at $3,546,000 after buying an additional 855 shares during the last quarter. Holderness Investments Co. boosted its position in shares of UnitedHealth Group by 2.4% during the second quarter. Holderness Investments Co. now owns 10,764 shares of the healthcare conglomerate’s stock valued at $2,627,000 after buying an additional 250 shares during the last quarter. Finally, Jensen Investment Management Inc. boosted its position in shares of UnitedHealth Group by 13.9% during the second quarter. Jensen Investment Management Inc. now owns 1,817,289 shares of the healthcare conglomerate’s stock valued at $443,437,000 after buying an additional 221,097 shares during the last quarter. Institutional investors own 85.65% of the company’s stock.
In other news, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 29th. The stock was sold at an average price of $241.99, for a total value of $2,419,900.00. Following the completion of the transaction, the director now owns 187,663 shares in the company, valued at approximately $45,412,569.37. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $246.40, for a total value of $1,232,000.00. Following the completion of the transaction, the director now owns 187,979 shares of the company’s stock, valued at approximately $46,318,025.60. The disclosure for this sale can be found here. In the last quarter, insiders sold 37,000 shares of company stock valued at $9,195,620. Company insiders own 0.87% of the company’s stock.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The business had revenue of $60.60 billion for the quarter, compared to the consensus estimate of $60.59 billion. During the same quarter in the previous year, the company posted $3.14 EPS. The company’s revenue was up 8.0% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Inc will post 14.84 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.76%. The ex-dividend date is Friday, September 13th. UnitedHealth Group’s dividend payout ratio (DPR) is 33.54%.
Several research analysts have issued reports on the company. Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 target price on the stock in a research report on Monday, July 22nd. Oppenheimer set a $312.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a research report on Monday, July 15th. Cantor Fitzgerald set a $310.00 target price on UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. Finally, UBS Group assumed coverage on UnitedHealth Group in a research report on Tuesday, April 23rd. They issued a “neutral” rating and a $238.00 target price on the stock. One research analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have given a buy rating to the stock. UnitedHealth Group currently has an average rating of “Buy” and an average target price of $295.06.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Momentum Investing
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.